Long-term Clinical Course of Decompensated Alcoholic Cirrhosis: A Prospective Study of 165 Patients.

Link to article at PubMed

Long-term Clinical Course of Decompensated Alcoholic Cirrhosis: A Prospective Study of 165 Patients.

J Clin Gastroenterol. 2011 Aug 2;

Authors: Alvarez MA, Cirera I, Solà R, Bargalló A, Morillas RM, Planas R

BACKGROUND:: Prognosis of decompensated alcoholic cirrhosis is based mainly on studies that included patients with different severities of liver disease and did not recognize either hepatitis C virus epidemic or changes in clinical management of cirrhosis. AIM:: To define the long-term course after the first hepatic decompensation in alcoholic cirrhosis. METHODS:: Prospective inclusion at the start point of decompensated cirrhosis of 165 consecutive patients with alcoholic cirrhosis without known hepatocellular carcinoma hospitalized from January 1998 to December 2001 was made. Follow-up was maintained until death or the end of the observation period (April 1, 2010). RESULTS:: The patients were followed for 835.75 patient years. Median age was 56 years (95% confidence interval: 54-58). Baseline Child-Pugh score was 9 (95% CI: 8-9), and model for end-stage liver disease (MELD) was 13.8 (95% CI: 12.5-14.7). Ascites was the most frequent first decompensation (51%). During follow-up, 99 (60%) patients were abstinent, hepatocellular carcinoma developed in 18 (11%) patients, and 116 patients died (70%). Median overall survival was 61 months (95% CI: 48-74). Median survival probability after onset of hepatic encephalopathy (HE) was only 14 months (95% CI: 5-23). Age, baseline MELD, albumin, development of HE, and persistence of alcohol use were independently correlated with mortality. CONCLUSIONS:: Patients with alcoholic cirrhosis show a high frequency of complications. The low mortality rate in our cohort of patients probably reflects the improvement in the management of patients with cirrhosis; it is mainly influenced by baseline MELD, age, HE development, and continued abstinence. Patients who develop HE should be considered for hepatic transplantation.

PMID: 21814145 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *